Literature DB >> 22157697

Bone marrow with gelatinous transformation associated with residual disease in imatinib mesylate-treated chronic myelogenous leukaemia (CML).

Beenu Thakral, Bryce Higa, Girish Venkataraman, Milind M Velankar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22157697     DOI： 10.1097/PAT.0b013e32834e42df

Source DB:  PubMed          Journal:  Pathology        ISSN： 0031-3025            Impact factor:   5.306


× No keyword cloud information.
  4 in total

1.  Gelatinous transformation of bone marrow following the use of dasatinib in a patient with philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Sanjeev Kumar Sharma; Dharma Choudhary; Anil Handoo; Gaurav Kharya; Nitin Gupta; Punita Pavecha; Ritu Chadha
Journal:  Leuk Res Rep       Date:  2013-01-07

2.  Gelatinous Marrow Transformation in an Imatinib-Treated CML Patient with Pancytopenia Following Severe Sepsis.

Authors:  Pallavi Agrawal; Prashant Sharma; Vikram Narang; Neelam Varma; Pankaj Malhotra; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2012-08-23       Impact factor: 0.900

3.  Gelatinous Marrow Transformation Associated with Imatinib: Case Report and Literature Review.

Authors:  E Chang; G Rivero; B Jiang; S Yellapragada; P Thiagarajan
Journal:  Case Rep Hematol       Date:  2017-01-04

Review 4.  Gelatinous transformation of bone marrow: rare or underdiagnosed?

Authors:  Khushdeep Kaur Shergill; Gagandeep Singh Shergill; Hari Janardanan Pillai
Journal:  Autops Case Rep       Date:  2017-12-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.